SESAME: Observational Study with Metvix daylight in AK

• Research type

  Research Study

• Full title

  Observational study to evaluate clinical practice and satisfaction with Metvix® Daylight Photodynamic Therapy in the treatment of mild and/or moderate Actinic Keratosis of the face and/or the scalp

• IRAS ID

  192216

• Contact name

  John Lear

• Contact email

  John.Lear@cmft.nhs.uk

• Sponsor organisation

  Galderma

• Clinicaltrials.gov Identifier

  Parexel, 222203

• Duration of Study in the UK

  0 years, 9 months, 1 days

• Research summary

  In the current observational study, we aim to evaluate the clinical practice and physician and patient
  satisfaction of Metvix® Daylight Photodynamic Therapy (DL-PDT) for the treatment of mild to moderate
  Actinic Keratosis on the face and scalp. This treatment involves a specific procedure that may actually vary
  in practice.

• REC name

  North East - Newcastle & North Tyneside 1 Research Ethics Committee

• REC reference

  15/NE/0413

• Date of REC Opinion

  4 Dec 2015

• REC opinion

  Favourable Opinion